Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Partial IgA-Deficiency with Increased Th2-Type Cytokines in TGF-β1 Knockout Mice
1999
Mesenchymal stem cells avoid allogeneic rejection
2005
Transforming growth factor-β in T-cell biology
2002
Arthritis in DBA/1 Mice Induced with Passively Transferred Type II Collagen Immune Serum
1990
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
2000 StandoutNature
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
1995 Standout
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression.
1996
Transforming growth factor beta (TGF-?) in inflammation: A cause and a cure
1992
The effect of norepinephrine on endotoxin-mediated macrophage activation
1991
Induction of erosive arthritis in mice after passive transfer of anti-type II collagen antibodies
1988
Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage
1990
Regulatory T Cells
2000 StandoutNobel
Isolation and Function of Human Dendritic Cells
1994
CD4+ T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation
2000
TGF-β1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression
2000
Induction of tolerance in peripheral T cells with monoclonal antibodies
1990
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Developmental regulation of MHC class II transport in mouse dendritic cells
1997 StandoutNatureNobel
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement
1992
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Analysis of Diffrentiation and Transformation of Cells by Lectins
1988
Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells
1990
Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
2003
Adhesion receptors of the immune system
1990 StandoutNature
Molecular cloning and expression of a receptor for human tumor necrosis factor
1990
The Fas Death Factor
1995 StandoutScience
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
The progression of the inflammation in established collagen‐induced arthritis can be altered by treatments with immunological or pharmacological agents which inhibit T cell activities
1988
TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling Complex
1996
TGF‐β: A Possible Autocrine Immune Regulator
2007
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
1992 StandoutNature
Therapeutic vaccines for cancer: an overview of clinical trials
2014
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
1998 StandoutNature
TGF-β1: immunosuppressant and viability factor for T lymphocytes
1999
The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
2000
Expression of Transgene Encoded TGF-β in Islets Prevents Autoimmune Diabetes in NOD Mice by a Local Mechanism
2002
Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF- 1 on CD4+ and CD8+ naive human T-cells
2004
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
1991
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
The Transforming Growth Factor‐Betas: A New Family of Immunoregulatory Molecules
1990
Cancer-related inflammation
2008 StandoutNature
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways
1996 Standout
Chapter 5 Emergence of the Th17 Pathway and Its Role in Host Defense
2008
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Experimental allergic encephalomyelitis: Neutralizing antibody to TGFβ1 enhances the clinical severity of the disease
1993
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Decreased Production of TGF-β by Lymphocytes from Patients with Systemic Lupus Erythematosus
1998
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Constitutive synthesis of tumor necrosis factor in the thymus.
1992 StandoutNobel
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking
1998 StandoutScienceNobel
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.
1992 StandoutNobel
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1.
1995
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
1995 Science
Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
1993
Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.
1996
LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytes
1987
Role of T lymphocytes in murine collagen induced arthritis
1986
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
1992
Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.
1991
Low Dose TGF-β Attenuates IL-12 Responsiveness in Murine Th Cells
1998
Transforming growth factor beta is protective in host resistance against Listeria monocytogenes infection in mice
1996
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
1990
The two different receptors for tumor necrosis factor mediate distinct cellular responses.
1991
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.
1988
Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
1998
Death Receptors: Signaling and Modulation
1998 StandoutScience
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.
2000
Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1.
1990
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells.
1998
Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice.
1999
Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.
1991
Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.
1998
Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.
1994 StandoutNobel
Engagement of Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor β (TGF-β) Production by Murine CD4+ T Cells
1998
Transforming Growth Factor β1 Inhibits Fas Ligand Expression and Subsequent Activation-induced Cell Death in T Cells via Downregulation of c-Myc
1999
Transforming Growth Factor-β Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis
2004
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.
1994 StandoutNobel
TGF-β1 Attenuates the Acquisition and Expression of Effector Function by Tumor Antigen-Specific Human Memory CD8 T Cells
2005
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.
1991
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors
1991
Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice.
1994
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2band dose-dependent requirement of H-2g7for diabetes in NOD mice
2008 StandoutNobel
The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex
1996
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
1997 Standout
Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis
1995
Maintenance of in Vivo Tolerance by Persistence of Antigen
1992 StandoutScienceNobel
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
2000 StandoutNobel
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
1993 StandoutNobel
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
1993 Standout
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
In vivotreatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees
1993
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
1997
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
1992 Standout
Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice.
1992
Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.
1994 StandoutNobel
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
1986
Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-β in ANA-1 cells
1998
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
1996 Standout
Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.
1994
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
1993 StandoutScience
Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process.
1994
T-cell subsets in autoimmunity
1993
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
1996
Works of Gerald Ranges being referenced
Genomic Cloning and Heterologous Expression of Human Differentiation-Stimulating Factor
1989
Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression.
1995
In Vivo Modulation of Murine Collagen Induced Arthritis
1988
Distinct Roles of the Two Tumor Necrosis Factor (TNF) Receptors in Modulating TNF and Lymphotoxin α Effects
1996
Tumor necrosis factor-alpha as a proliferative signal for an IL-2-dependent T cell line: strict species specificity of action.
1989
Functional Relationships of LYT-2 and LYT-3 Expression and T-Cell Cytotoxicity: A New Model System
1985
Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer.
1994
Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma.
1988
Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines.
1988
Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.
1985
Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.
1988
Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.
1987
In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis.
1988
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.
1991
Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice
1989
The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.
1988
Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B.
1994
Suppression of T cell cytotoxicity by nude mouse spleen cells: reversal by monosaccharides and interleukin 2.
1983